Who owns Liminatus Pharma Inc A?
- Ticker: LIMN
- CUSIP Number: 53271x108
Tip: Access positions for across all investors
Analyze quarterly positions in Liminatus Pharma Inc A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Liminatus Pharma Inc A stock
Who bought or sold Liminatus Pharma Inc A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 73k | $123k | 0% | Sep 2025 |
|
| Geode Capital Management | 64k | $107k | 0% | Sep 2025 |
|
| UBS Group | 41k | $68k | 29% | Sep 2025 |
|
| Jane Street | 40k | $66k | 100% | Sep 2025 |
|
| State Street Corporation | 19k | $32k | 0% | Sep 2025 |
|
| BlackRock | 13k | $22k | 0% | Sep 2025 |
|
| Squarepoint Ops | 10k | $17k | 100% | Sep 2025 |
|
| Tower Research Capital | 1.8k | $3.1k | 264% | Sep 2025 |
|
| Farther Finance Advisors | 31.00 | $51.999400 | 100% | Sep 2025 |
|
Who sold out of Liminatus Pharma Inc A?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Royal Bank of Canada | Jun 2025 | 2.9k | $32k |
| Barclays | Jun 2025 | 184.00 | $2.0k |
| SBI Securities | Jun 2025 | 52.00 | $579.997600 |